Most Recent
US-based haircare company Amika has taken Kmart and Target to court for allegedly selling knockoff versions of its products.
Swiss drug maker Novartis has lost its bid to have Pharmacor's Valtresto trade mark removed for non use, with an IP Australia delegate finding that an injunction in a fight over the patent for Novartis' heart drug Entresto was an obstacle to using the mark.
Lawyers stuck inside by the dreary, cold weather have been keeping busy penning a slew of new suits targeting the likes of Coles, REA and Nine.
The start-up behind Hungry Jack's plant-based 'Rebel Whopper' has won court approval to patent a fake meat product after an opponent didn't participate in its appeal of an IP Australia ruling that held the patent lacked inventive step.
The gender pay gap remains a sore spot for IP boutiques and one major US-based litigation firm, according to data released by the Workplace Gender Equality Agency.
Bayer and Teva have lost their challenge to Indian drug maker Cipla’s extension of its patent for an allergy medication, with IP Australia finding a failure to pay renewal fees on time was due to a genuine error.
The start-up behind Hungry Jack's plant-based 'Rebel Whopper' wants a court to review IP Australia's decision that a proposed patent covering its fake meat product didn't pass muster.
V2food, the CSIRO-backed start-up behind Hungry Jack's plant-based 'Rebel Whopper', has lost its bid to patent a product that changes colour when cooked in order to imitate the “meat experience”.
German drug maker Merck KGaA is fighting US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia, five years after their intellectual property spat was settled.
The CSIRO has successfully appealed a decision that blocked the government agency’s application to patent a method of producing high-fibre wheat.